Browsing by Author Best, J

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2010Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetesBarter, Philip; Keech, Anthony (Tony); Mann, Kirsty; Simes, Robert John; Best, J; Ehnholm, Christian; Hamwood, S; Sullivan, David Richmond; Taskinen, M.; Central Clinical School: Heart Research Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAbility of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes, Diabetologia: clinical and experimental diabetes and metabolism, vol.53, 9,pp 1846-1855
2017Baseline circulating FGF21 concentrations and increase after fenofibrate treatment predict more rapid glycemic progression in type 2 diabetes: Results from the FIELD studyBarter, Philip; Januszewski, Andrzej Szczesny; Jenkins, Alicia; Keech, Anthony (Tony); O'Connell, Rachel; Ong, Kwok; Rye, Kerry-Anne; Simes, Veronica; Sullivan, David; Waldman, Boris; Best, J; Colman, P; Scott, R; Taskinen, Marja-Riitta; Xu, A; Central Clinical School: Heart Research Institute; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Central Clinical School: Heart Research Institute; Central Clinical School: Heart Research Institute; Plant & Food Sciences; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreBaseline circulating FGF21 concentrations and increase after fenofibrate treatment predict more rapid glycemic progression in type 2 diabetes: Results from the FIELD study, Clinical Chemistry, vol.63, 7, 2017,pp 1261-1270
2010Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) StudyDonoghoe, Mark; Gebski, Val; Keech, Anthony (Tony); O'Connell, Rachel; Simes, Robert John; Ting, R; Best, J; Davis, T. M. E.; Drury, P.L.; Glasziou, Paul .P.; Jenkins, Alicia J.; Kesaniemi, Y. Antero; Scott, R; Sullivan, D; Whiting, M. J.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEffects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study, Diabetologia: clinical and experimental diabetes and metabolism, vol.54, 2,pp 280-290
2016Impact of insulin initiation on glycaemic variability and glucose profiles in a primary healthcare Type 2 diabetes cohort: Analysis of continuous glucose monitoring data from the INITIATION studyJenkins, Alicia; Best, J; Blackberry, Irene; Cohen, Neale; Furler, John S.; Ginnivan, Louise; Gorelik, Alexandra; Manski-Nankervis, Jo Anne; O'Neal, David N; Vasanthakumar, Sheran; Yates, Christopher; Young, D; NH&MRC Clinical Trials CentreImpact of insulin initiation on glycaemic variability and glucose profiles in a primary healthcare Type 2 diabetes cohort: Analysis of continuous glucose monitoring data from the INITIATION study, Diabetic Medicine, vol.33, 6, 2016,pp 803-811
2013The metabolic syndrome and CVD outcomes for a central Australian cohortJenkins, Alicia; Best, J; Brown, Alex; Daniell, Mark; Luke, Joanne; McDermott, Robyn; O'Dea, Kerin; Rowley, Kevin; Wang, Zaimin; Wang, Zhiqiang; School of Public Health: NH&MRC Clinical Trials CentreThe metabolic syndrome and CVD outcomes for a central Australian cohort, Diabetes Research and Clinical Practice, vol.100, 3, 2013,pp e70-e73